KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Nutanix (NTNX) Research & Development (2016 - 2026)

Nutanix (NTNX) has disclosed Research & Development for 12 consecutive years, with $202.3 million as the latest value for Q1 2026.

  • Quarterly Research & Development rose 10.65% to $202.3 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $769.8 million through Jan 2026, up 12.65% year-over-year, with the annual reading at $736.8 million for FY2025, 15.31% up from the prior year.
  • Research & Development for Q1 2026 was $202.3 million at Nutanix, up from $187.5 million in the prior quarter.
  • The five-year high for Research & Development was $202.3 million in Q1 2026, with the low at $141.9 million in Q1 2022.
  • Average Research & Development over 5 years is $163.2 million, with a median of $159.2 million recorded in 2024.
  • The sharpest move saw Research & Development fell 1.78% in 2022, then rose 17.08% in 2025.
  • Over 5 years, Research & Development stood at $149.4 million in 2022, then grew by 1.69% to $152.0 million in 2023, then grew by 14.47% to $174.0 million in 2024, then rose by 7.77% to $187.5 million in 2025, then increased by 7.88% to $202.3 million in 2026.
  • According to Business Quant data, Research & Development over the past three periods came in at $202.3 million, $187.5 million, and $193.7 million for Q1 2026, Q4 2025, and Q3 2025 respectively.